Co‐administration of curcumin with other phytochemicals improves anticancer activity by regulating multiple molecular targets

Abstract Natural plant phytochemicals are effective against different types of diseases, including cancer. Curcumin, a powerful herbal polyphenol, exerts inhibitory effects on cancer cell proliferation, angiogenesis, invasion, and metastasis through interaction with different molecular targets. However, the clinical use of curcumin is limited due to poor solubility in water and metabolism in the liver and intestine. The synergistic effects of curcumin with some phytochemicals such as resveratrol, quercetin, epigallocatechin‐3‐gallate, and piperine can improve its clinical efficacy in cancer treatment. The present review specifically focuses on anticancer mechanisms related to the co‐administration of curcumin with other phytochemicals, including resveratrol, quercetin, epigallocatechin‐3‐gallate, and piperine. According to the molecular evidence, the phytochemical combinations exert synergistic effects on suppressing cell proliferation, reducing cellular invasion, and inducing apoptosis and cell cycle arrest. This review also emphasizes the significance of the co‐delivery vehicles‐based nanoparticles of such bioactive phytochemicals that could improve their bioavailability and reduce their systemic dose. Further high‐quality studies are needed to firmly establish the clinical efficacy of the phytochemical combinations.